Assyro AI

Orange Book product · Brand (NDA)

ATROVENT HFA

IPRATROPIUM BROMIDE

Brand (NDA)NDA 021527TE ABRX BOEHRINGER INGELHEIM

At a glance

Nov 27, 2004

Approved

Brand (NDA)

Application

AB

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 27, 2004

    21 yr 10 mo ago

  2. Today

  3. Patent 8474447 expires

    Listed drug product patent expiration.

    Jan 17, 2030

    in 3 yr 8 mo

Pharmaceutical detail

Active ingredient

IPRATROPIUM BROMIDE

Strength

0.021MG/INH

Dosage form

AEROSOL, METERED

Route

INHALATION

TE code

AB

Application

NDA 021527

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8474447Jan 17, 2030in 3 yr 8 mo
ProductDelisted
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.